288 related articles for article (PubMed ID: 20622265)
41. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
[TBL] [Abstract][Full Text] [Related]
42. Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: implications for the hosts' innate immune response.
Kundu K; Dutta K; Nazmi A; Basu A
Cell Immunol; 2013; 285(1-2):100-10. PubMed ID: 24140964
[TBL] [Abstract][Full Text] [Related]
43. The suppressors of cytokine signalling (SOCS).
Kile BT; Alexander WS
Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
[TBL] [Abstract][Full Text] [Related]
44. SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes.
Saint-Germain E; Mignacca L; Vernier M; Bobbala D; Ilangumaran S; Ferbeyre G
Aging (Albany NY); 2017 Oct; 9(10):2137-2162. PubMed ID: 29081404
[TBL] [Abstract][Full Text] [Related]
45. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells.
Yu CR; Mahdi RM; Ebong S; Vistica BP; Gery I; Egwuagu CE
J Biol Chem; 2003 Aug; 278(32):29752-9. PubMed ID: 12783879
[TBL] [Abstract][Full Text] [Related]
46. Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.
Evans MK; Yu CR; Lohani A; Mahdi RM; Liu X; Trzeciak AR; Egwuagu CE
Oncogene; 2007 Mar; 26(13):1941-8. PubMed ID: 17001312
[TBL] [Abstract][Full Text] [Related]
47. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis.
Townsend PA; Scarabelli TM; Davidson SM; Knight RA; Latchman DS; Stephanou A
J Biol Chem; 2004 Feb; 279(7):5811-20. PubMed ID: 14602726
[TBL] [Abstract][Full Text] [Related]
48. Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.
Saudemont A; Hamrouni A; Marchetti P; Liu J; Jouy N; Hetuin D; Colucci F; Quesnel B
Cancer Res; 2007 May; 67(9):4491-8. PubMed ID: 17483365
[TBL] [Abstract][Full Text] [Related]
49. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
Valentino L; Pierre J
Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
[TBL] [Abstract][Full Text] [Related]
50. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
51. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
[TBL] [Abstract][Full Text] [Related]
52. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
[TBL] [Abstract][Full Text] [Related]
53. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3.
Tamiya T; Kashiwagi I; Takahashi R; Yasukawa H; Yoshimura A
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):980-5. PubMed ID: 21508344
[TBL] [Abstract][Full Text] [Related]
54. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
55. Respiratory Syncytial Virus Nonstructural Proteins Upregulate SOCS1 and SOCS3 in the Different Manner from Endogenous IFN Signaling.
Zheng J; Yang P; Tang Y; Pan Z; Zhao D
J Immunol Res; 2015; 2015():738547. PubMed ID: 26557722
[TBL] [Abstract][Full Text] [Related]
56. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury.
Yasukawa H; Yajima T; Duplain H; Iwatate M; Kido M; Hoshijima M; Weitzman MD; Nakamura T; Woodard S; Xiong D; Yoshimura A; Chien KR; Knowlton KU
J Clin Invest; 2003 Feb; 111(4):469-78. PubMed ID: 12588885
[TBL] [Abstract][Full Text] [Related]
57. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling.
Haque SJ; Harbor PC; Williams BR
J Biol Chem; 2000 Aug; 275(34):26500-6. PubMed ID: 10950967
[TBL] [Abstract][Full Text] [Related]
58. Dectin-1 stimulation induces suppressor of cytokine signaling 1, thereby modulating TLR signaling and T cell responses.
Eberle ME; Dalpke AH
J Immunol; 2012 Jun; 188(11):5644-54. PubMed ID: 22547696
[TBL] [Abstract][Full Text] [Related]
59. Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling.
Gingras S; Parganas E; de Pauw A; Ihle JN; Murray PJ
J Biol Chem; 2004 Dec; 279(52):54702-7. PubMed ID: 15491990
[TBL] [Abstract][Full Text] [Related]
60. SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells.
Zitzmann K; Brand S; De Toni EN; Baehs S; Göke B; Meinecke J; Spöttl G; Meyer HH; Auernhammer CJ
Cancer Res; 2007 May; 67(10):5025-32. PubMed ID: 17510435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
